P01-024 – Vascular risk assessment and MMP-3 gene in FMF
نویسندگان
چکیده
منابع مشابه
P01-024 – Vascular risk assessment and MMP-3 gene in FMF
Introduction The patients characterized with chronic subclinical inflammation even during attack-free periods, are now considered to have an increased risk of atherosclerotic complications as well as other autoinflammatory disease. Damage to the arterial wall due to atherosclerosis causes increased arterial stiffness. Pulse wave velocity (PWV), a noninvasive measure of arterial stiffness, is ac...
متن کاملPReS-FINAL-2205: Vascular risk assesment and MMP-3 gene in FMF
Introduction The patients characterized with chronic subclinical inflammation even during attack-free periods, are now considered to have an increased risk of atherosclerotic complications as well as other autoinflammatory disease. Damage to the arterial wall due to atherosclerosis causes increased arterial stiffness. Pulse wave velocity (PWV), a noninvasive measure of arterial stiffness, is ac...
متن کاملP01-043 – Comparative characteristic of FMF and FMF with HSP
Methods Clinical studies conducted in 61 non complicated of amyloidosis FMF children in the Republican FMF Children Center, Center “Arabkir”. The age of the patients varies from 5-15. Three patients of FMF are accompanied with HSP. We are selected as a control group of 11 healthy people in practice.Biochemical studies carried out in Hematological Center of Armenia. In erythrocytes of membrane w...
متن کاملP01-003 – Bleeding disorder in FMF
Introduction The most serious complication in Familial Mediterranean fever (FMF) is the development of amyloidosis, which usually determines the prognosis. Amyloid deposition can be systemic or organ-specific. The clinical features of amyloidosis are dependent on the organs involved, type of amyloidosis, rate of amyloid deposition and amount of amyloid fibrils. Organ dysfunction can cause life-...
متن کاملP01-029 – Microscopic hematuria in FMF
Methods We studied consecutive FMF patients, who came for a pre-scheduled follow up visit in the FMF clinic for the presence of microscopic hematuria, defined as ≥5 RBC/HPF or ≥25RBC/μl in urine analysis performed during remission, recorded at least once in the 3 previous clinic visits. Exclusions were known kidney, urinary tract, prostate or gynecologic diseases, bleeding or thrombotic diathes...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Rheumatology
سال: 2013
ISSN: 1546-0096
DOI: 10.1186/1546-0096-11-s1-a28